BOC
TEVA icon

Bull Oak Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bull Oak Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-82
Closed -$836 – 67
2023
Q3 		$836 Buy
+82
New +$764 ﹤0.01% 75

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Bull Oak Capital's TEVA Position: Q4 2023 in Review

Bull Oak Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2023, closing a stake of 82 shares — an estimated $836 sold.

Bull Oak Capital first reported a position in TEVA in Q3 2023 and held it in 1 quarter. The position peaked at $836 in Q3 2023. 448 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Bull Oak Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2023 after selling out during the quarter.
  • Bull Oak Capital sold 82 Teva Pharmaceutical Industries Limited shares in Q4 2023, an estimated $836.
  • Bull Oak Capital first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and held it in 1 quarter.
  • Bull Oak Capital's Teva Pharmaceutical Industries Limited position peaked at $836 in Q3 2023.
  • 448 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2023.

Based on Bull Oak Capital's 13F filing for Q4 2023, filed 29 Jan 2024.